Federated Hermes reports 3.87% IDEAYA stake
Federated Hermes, Inc. filed Amendment No. 3 to a Schedule 13G reporting beneficial ownership of 3,395,771 shares of IDEAYA Biosciences, Inc. common stock, representing 3.87% of the class as of 12/31/2025.
Rhea-AI Filing Summary
Federated Hermes, Inc. filed Amendment No. 3 to a Schedule 13G reporting beneficial ownership of 3,395,771 shares of IDEAYA Biosciences, Inc. common stock, representing 3.87% of the class as of 12/31/2025. The same share amount and percentage are reported for the Voting Shares Irrevocable Trust, and for Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, reflecting shared or sole voting and dispositive powers as disclosed on each cover page.
Federated Hermes, the trust, and the individual filers state that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of IDEAYA. They also declare, in accordance with Rule 13d-4, that this filing should not be construed as an admission that any of them is the beneficial owner of securities held by the managed funds, and they expressly disclaim beneficial ownership of those securities. The filing indicates ownership of 5 percent or less of IDEAYA’s common stock.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in IDEAYA Biosciences does Federated Hermes (FHI) report?
Who are the reporting persons in this IDEAYA Biosciences Schedule 13G/A?
How much of IDEAYA Biosciences’ common stock is reported as owned in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.